COMPARISON OF DAUNORUBICIN AND DAUNORUBICIN-DNA COMPLEX IN THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
PAUL, C
BJORKHOLM, M
CHRISTENSON, I
ENGSTEDT, L
GAHRTON, G
HAST, R
HOLM, G
KILLANDER, A
LANTZ, B
LOCKNER, D
LONNQVIST, B
MELLSTEDT, H
PALMBLAD, J
PETERSON, C
SIMONSSON, B
STALFELT, AM
UDEN, AM
WADMAN, B
OBERG, G
机构：
[1] HUDDINGE HOSP,DEPT MED,S-14186 HUDDINGE,SWEDEN
[2] DANDERYDS HOSP,DEPT MED,S-18288 DANDERYD,SWEDEN
[3] KAROLINSKA HOSP,DEPT MED,S-10401 STOCKHOLM,SWEDEN
[4] S HOSP,DEPT MED,S-10064 STOCKHOLM,SWEDEN
[5] REG HOSP OREBRO,DEPT MED,S-70185 OREBRO,SWEDEN
[6] UNIV UPPSALA HOSP,DEPT MED,S-75014 UPPSALA,SWEDEN
[7] HUDDINGE HOSP,DEPT CLIN IMMUNOL,S-14186 HUDDINGE,SWEDEN
[8] KAROLINSKA HOSP,RADIUM HEMMET,S-10401 STOCKHOLM,SWEDEN
[9] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
[10] HUDDINGE HOSP,DEPT PHARMACOL,S-14186 HUDDINGE,SWEDEN
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1981年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 73
页数：9
相关论文
共 50 条
  • [11] A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia
    Goemans, Bianca F.
    Zwaan, Christian M.
    Reinhardt, Dirk
    Gibson, Brenda E. S.
    Hahlen, K.
    Kaspers, Gert Jan L.
    HAEMATOLOGICA, 2006, 91 (11) : 1573 - 1574
  • [12] Daunorubicin for the treatment of acute myeloid leukemia
    Bertuzzi, Clara
    Paolini, Stefania
    Visani, Giuseppe
    Piccaluga, Pier Paolo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (10): : 1075 - 1087
  • [13] COMPARATIVE STUDIES ON THE INVITRO KILLING OF HUMAN NORMAL AND LEUKEMIC CLONOGENIC CELLS (CFUC) BY DAUNORUBICIN, DAUNORUBICINOL, AND DAUNORUBICIN-DNA COMPLEX
    BERAN, M
    ANDERSSON, B
    EKSBORG, S
    EHRSSON, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (01) : 19 - 24
  • [14] QUANTITATIVE ASSAY OF PLASMA DEOXYRIBONUCLEASE ACTIVITY AND ITS INHIBITION BY DAUNORUBICIN-DNA COMPLEX
    HULHOVEN, R
    DESAGER, JP
    ZENEBERGH, A
    BULLETIN DES SOCIETES CHIMIQUES BELGES, 1978, 87 (07): : 499 - 503
  • [15] DAUNORUBICIN IN PATIENTS WITH RELAPSED AND REFRACTORY ACUTE NONLYMPHOBLASTIC LEUKEMIA PREVIOUSLY TREATED WITH ANTHRACYCLINE
    VELU, T
    DEBUSSCHER, L
    STRYCKMANS, P
    AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (03) : 224 - 225
  • [16] DAUNORUBICIN, DAUNORUBICINOL AND DNA PLASMA KINETICS AFTER IV ADMINISTRATION OF DAUNORUBICIN-DNA COMPLEX IN THE RABBIT .2. EFFECTS OF RES-BLOCKADE
    HULHOVEN, R
    HARVENGT, C
    BIOMEDICINE EXPRESS, 1980, 33 (02): : 44 - 47
  • [17] ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF TREATMENT BY DAUNORUBICIN
    BERNARD, J
    WEIL, M
    BOIRON, M
    JACQUILLAT, C
    FLANDRIN, G
    GEMON, MF
    BLOOD, 1973, 41 (04) : 489 - 496
  • [18] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [19] Levan modified DNA biosensor for voltammetric detection of daunorubicin-DNA interaction
    Congur, Gulsah
    Eksin, Ece
    Erdem, Arzum
    SENSORS AND ACTUATORS B-CHEMICAL, 2021, 326
  • [20] UPTAKE AND DISTRIBUTION OF DAUNORUBICIN AND DAUNORUBICIN-DNA COMPLEX IN MICE AS STUDIED BY WHOLE-BODY AUTO-RADIOGRAPHY AND LIQUID-CHROMATOGRAPHY
    ANDERSSON, B
    BERAN, M
    EBERHARDSSON, B
    EKSBORG, S
    SLANINA, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 159 - 167
12345